Abstract:Introduction: Lung cancer is one of the most frequent neoplasms worldwide with approximately 2.2 million new cases and 1.8 million deaths each year. The expression levels of programmed death ligand-1 (PDL1) demonstrate a complex association with lung cancer. Neuroblastoma is a high-risk malignant tumor and is mainly involved in childhood patients. Identification of new biomarkers for these two diseases can significantly promote their diagnosis and therapy. However, in vivo experiments to discover potential biomarkers are costly and laborious. Consequently, artificial intelligence technologies, especially machine learning methods, provide a powerful avenue to find new biomarkers for various diseases. Methods: We developed a machine learning-based method named LDAenDL to detect potential long noncoding RNA (lncRNA) biomarkers for lung cancer and neuroblastoma using an ensemble of a deep neural network and LightGBM. LDAenDL first computes the Gaussian kernel similarity and functional similarity of lncRNAs and the Gaussian kernel similarity and semantic similarity of diseases to obtain their similar networks. Next, LDAenDL combines a graph convolutional network, graph attention network, and convolutional neural network to learn the biological features of the lncRNAs and diseases based on their similarity networks. Third, these features are concatenated and fed to an ensemble model composed of a deep neural network and LightGBM to find new lncRNA–disease associations (LDAs). Finally, the proposed LDAenDL method is applied to identify possible lncRNA biomarkers associated with lung cancer and neuroblastoma. Results: The experimental results show that LDAenDL computed the best AUCs of 0.8701, 107 0.8953, and 0.9110 under cross-validation on lncRNAs, diseases, and lncRNA-disease pairs on Dataset 1, respectively, and 0.9490, 0.9157, and 0.9708 on Dataset 2, respectively. Furthermore, AUPRs of 0.8903, 0.9061, and 0.9166 under three cross-validations were obtained on Dataset 1, and 0.9582, 0.9122, and 0.9743 on Dataset 2. The results demonstrate that LDAenDL significantly outperformed the other four classical LDA prediction methods (i.e., SDLDA, LDNFSGB, IPCAF, and LDASR). Case studies demonstrate that CCDC26 and IFNG-AS1 may be new biomarkers of lung cancer, SNHG3 may associate with PDL1 for lung cancer, and HOTAIR and BDNF-AS may be potential biomarkers of neuroblastoma. Conclusion: We hope that the proposed LDAenDL method can help the development of targeted therapies for these two diseases.

Early stage lung cancer diagnosis based on neural network ensemble []

Lung Cancer Cell Identification Based on Artificial Neural Network Ensembles

Two-Stage Deep Neural Network Via Ensemble Learning for Melanoma Classification

Modality-Collaborative AI Model Ensemble for Lung Cancer Early Diagnosis

An intelligent medical image understanding method using two-tier neural network ensembles

Deep learning ensemble 2D CNN approach towards the detection of lung cancer

Identification of Benign and Malignant Lung Nodules in CT Images Based on Ensemble Learning Method

Histopathological image analysis for breast cancer diagnosis by ensembles of convolutional neural networks and genetic algorithms

Image segmentation algorithm of lung cancer based on neural network model

Breast Cancer Histopathology Image Classification Using an Ensemble of Deep Learning Models

CNN-based Diagnosis System on Skin Cancer using Ensemble Method Weighted by Cubic Precision

Histopathological Gastric Cancer Detection on GasHisSDB Dataset Using Deep Ensemble Learning

The Deep Learning ResNet101 and Ensemble XGBoost Algorithm with Hyperparameters Optimization Accurately Predict the Lung Cancer

Optimizing Breast Cancer Detection With an Ensemble Deep Learning Approach

Predicting potential lncRNA biomarkers for lung cancer and neuroblastoma based on an ensemble of a deep neural network and LightGBM

System for Breast Cancer Diagnosis Based on Neural Network Ensemble

Computer-aided diagnosis of lung carcinoma using deep learning - a pilot study

Exploiting histopathological imaging for early detection of lung and colon cancer via ensemble deep learning model

A Convolutional Neural Network Based Ensemble Method for Cancer Prediction Using DNA Methylation Data

Clinical Application of Image Processing and Neural Network in Cytopathological Diagnosis of Lung Cancer